Immucor builds blood transfusion portfolio
This article was originally published in The Gray Sheet
Executive Summary
Immucor gains BioArray Solutions' BeadChip DNA analysis system for antigen determination for donors and recipients of blood transfusions under a $117 million acquisition deal announced March 11. The cash deal also gives Immucor a 19% equity interest in a new spin-off entity that will commercialize BioArray technology outside the fields of blood transfusion and transplantation. Immucor makes automated instruments and reagents that detect and identify the properties of cell and serum components of blood prior to transfusions